On November 19, 2024, the U.S. Food and Drug Administration (FDA) issued a warning letter to Colgate-Palmolive regarding significant violations of Current Good Manufacturing Practice (CGMP) regulations at its subsidiary Tom's of Maine's drug manufacturing facility in Maine. The issues were identified during an FDA inspection conducted in May 2024.
Key violations highlighted in the warning letter include:
Microbiological Contamination: The FDA found Pseudomonas aeruginosa and Ralstonia insidiosa in water samples, and Paracoccus yeei in finished OTC toothpaste products. The company failed to adequately investigate the impact of these contaminants on product quality and safety.
Inadequate Water System: The company did not adequately qualify its water system used for equipment cleaning and OTC drug product formulation. The Installation Qualification/Operational Qualification (IQ/OQ) lacked essential analyses for total organic carbon and conductivity, crucial for meeting product specifications. The absence of gram-negative microorganism analysis further raised safety concerns.
Building Maintenance Deficiencies: Inspections revealed black mold-like substances existing near both product-contact equipment and uneven surfaces in manufacturing areas. This finding indicates the company’s failure to maintain the facility in good repair as required by CGMP regulations.
The FDA has instructed Colgate-Palmolive/Tom’s of Maine to take immediate corrective actions, including a thorough assessment of manufacturing operations, detailed risk assessments, comprehensive investigations into contaminated batches, establishment of appropriate batch release specifications, submission of all necessary testing methods and results, submission of a remediation plan for the water system, etc.
ChemLinked Comments
Owned by Colgate-Palmolive since 2006, Tom's of Maine is well-known for marketing its products as made with safe and hardworking natural ingredients, as well as free from artificial flavors, fragrances, colors, sweeteners, and preservatives. The brand offers a range of personal care items, such as toothpaste, deodorants, and soap. The discovery of bacterial contamination in its toothpaste products has raised critical concerns about the quality control and safety of products marketed as natural and sustainable.
This incident highlights the critical need for strict quality control, robust facility maintenance, and adherence to CGMP regulations, especially for brands trusted for their eco-conscious and health-oriented values.